Anti-tetherin activities in Vpu-expressing primate lentiviruses

Retrovirology

Volumn 7, Issue , 2010, Pages

  Yang, Su J ^a   Lopez, Lisa A ^a   Hauser, Heiko ^a   Exline, Colin M ^a   Haworth, Kevin G ^a   Cannon, Paula M ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE PROTEIN; NEF PROTEIN; TETHERIN; UNCLASSIFIED DRUG; VPU PROTEIN; BST2 PROTEIN, HUMAN; HUMAN IMMUNODEFICIENCY VIRUS PROTEIN; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN; VIRUS PROTEIN; VPU PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CHIMPANZEE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRINAE; MACACA; MICROBIAL ACTIVITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN FUNCTION; SIMIAN IMMUNODEFICIENCY VIRUS; ANIMAL; DRUG ANTAGONISM; HUMAN IMMUNODEFICIENCY VIRUS; METABOLISM; PAN TROGLODYTES; PATHOGENICITY; PHYSIOLOGY; VIRUS RELEASE; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1; PAN; PRIMATES;

ANIMALS; ANTIGENS, CD; HUMAN IMMUNODEFICIENCY VIRUS PROTEINS; HUMANS; LENTIVIRUSES, PRIMATE; MEMBRANE GLYCOPROTEINS; PAN TROGLODYTES; VIRAL REGULATORY AND ACCESSORY PROTEINS; VIRUS RELEASE; VIRUS REPLICATION;

EID: 77949474957     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-7-13     Document Type: Article

References (50)

1. Neil SJD, Sandrin V, Sundquist WI, Bieniasz PD. An Interferon-[alpha]-Induced Tethering Mechanism Inhibits HIV-1 and Ebola Virus Particle Release but Is Counteracted by the HIV-1 Vpu Protein. Cell Host & Microbe 2007, 2:193-203.
2. Neil SJD, Zang T, Bieniasz PD. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 2008, 451:425-430. 10.1038/nature06553, 18200009.
3. Van Damme N, Goff D, Katsura C, Jorgenson RL, Mitchell R, Johnson MC, Stephens EB, Guatelli J. The Interferon-Induced Protein BST-2 Restricts HIV-1 Release and Is Downregulated from the Cell Surface by the Viral Vpu Protein. Cell Host & Microbe 2008, 3:245-252.
4. Jouvenet N, Neil SJD, Zhadina M, Zang T, Kratovac Z, Lee Y, McNatt M, Hatziioannou T, Bieniasz PD. Broad-Spectrum Inhibition of Retroviral and Filoviral Particle Release by Tetherin. J Virol 2009, 83:1837-1844. 10.1128/JVI.02211-08, 2643743, 19036818.
5. Kaletsky RL, Francica JR, Agrawal-Gamse C, Bates P. Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein. Proceedings of the National Academy of Sciences 2009, 106:2886-2891.
6. Sakuma T, Noda T, Urata S, Kawaoka Y, Yasuda J. Inhibition of Lassa and Marburg Virus Production by Tetherin. J Virol 2009, 83:I2382-2385.
7. Abada P, Noble B, Cannon PM. Functional Domains within the Human Immunodeficiency Virus Type 2 Envelope Protein Required To Enhance Virus Production. J Virol 2005, 79:3627-3638. 10.1128/JVI.79.6.3627-3638.2005, 1075700, 15731257.
8. Bour S, Schubert U, Peden K, Strebel K. The envelope glycoprotein of human immunodeficiency virus type 2 enhances viral particle release: a Vpu-like factor?. J Virol 1996, 70:820-829. 189884, 8551620.
9. Jia B, Serra-Moreno R, Neidermyer W, Rahmberg A, Mackey J, Fofana IB, Johnson WE, Westmoreland S, Evans DT. Species-Specific Activity of SIV Nef and HIV-1 Vpu in Overcoming Restriction by Tetherin/BST2. PLoS Pathog 2009, 5:e1000429. 10.1371/journal.ppat.1000429, 2673686, 19436700.
10. Zhang F, Wilson SJ, Landford WC, Virgen B, Gregory D, Johnson MC, Munch J, Kirchhoff F, Bieniasz PD, Hatziioannou T. Nef Proteins from Simian Immunodeficiency Viruses Are Tetherin Antagonists. Cell Host & Microbe 2009, 6:54-67.
11. Lim ES, Emerman M. Simian Immunodeficiency Virus SIVagm from African Green Monkeys Does Not Antagonize Endogenous Levels of African Green Monkey Tetherin/BST-2. J Virol 2009, 83:11673-11681. 10.1128/JVI.00569-09, 19726508.
12. Gupta RK, Mlcochova P, Pelchen-Matthews A, Petit SJ, Mattiuzzo G, Pillay D, Takeuchi Y, Marsh M, Towers GJ. Simian immunodeficiency virus envelope glycoprotein counteracts tetherin/BST-2/CD317 by intracellular sequestration. Proceedings of the National Academy of Sciences 2009,
13. McNatt MW, Zang T, Hatziioannou T, Bartlett M, Fofana IB, Johnson WE, Neil SJD, Bieniasz PD. Species-Specific Activity of HIV-1 Vpu and Positive Selection of Tetherin Transmembrane Domain Variants. PLoS Pathog 2009, 5:e1000300. 10.1371/journal.ppat.1000300, 2633611, 19214216.
14. Goffinet C, Allespach I, Homann S, Tervo H-M, Habermann A, Rupp D, Oberbremer L, Kern C, Tibroni N, Welsch S, Krijnse-Locker J, Banting G, Kräusslich HG, Fackler OT, Keppler OT. HIV-1 Antagonism of CD317 Is Species Specific and Involves Vpu-Mediated Proteasomal Degradation of the Restriction Factor. Cell Host & Microbe 2009, 5:285-297.
15. Gupta RK, Hue S, Schaller T, Verschoor E, Pillay D, Towers GJ. Mutation of a Single Residue Renders Human Tetherin Resistant to HIV-1 Vpu-Mediated Depletion. PLoS Pathog 2009, 5:e1000443. 10.1371/journal.ppat.1000443, 2678251, 19461879.
16. Rong L, Zhang J, Lu J, Pan Q, Lorgeoux R-P, Aloysius C, Guo F, Liu S-L, Wainberg MA, Liang C. The Transmembrane Domain of BST-2 Determines Its Sensitivity to Down-Modulation by Human Immunodeficiency Virus Type 1 Vpu. J Virol 2009, 83:7536-7546. 10.1128/JVI.00620-09, 2708638, 19474106.
17. Strebel K, Klimkait T, Maldarelli F, Martin MA. Molecular and biochemical analyses of human immunodeficiency virus type 1 vpu protein. J Virol 1989, 63:3784-3791. 250971, 2788224.
18. Schubert U, Bour S, Ferrer-Montiel AV, Montal M, Maldarell F, Strebel K. The two biological activities of human immunodeficiency virus type 1 Vpu protein involve two separable structural domains. J Virol 1996, 70:809-819. 189883, 8551619.
19. Dube M, Roy BB, Guiot-Guillain P, Mercier J, Binette J, Leung G, Cohen EA. Suppression of Tetherin-Restricting Activity upon Human Immunodeficiency Virus Type 1 Particle Release Correlates with Localization of Vpu in the trans-Golgi Network. J Virol 2009, 83:4574-4590. 10.1128/JVI.01800-08, 2668474, 19244337.
20. Mitchell RS, Katsura C, Skasko MA, Fitzpatrick K, Lau D, Ruiz A, Stephens EB, Margottin-Goguet F, Benarous R, Guatelli JC. Vpu Antagonizes BST-2-Mediated Restriction of HIV-1 Release via β-TrCP and Endo-Lysosomal Trafficking. PLoS Pathog 2009, 5:e1000450. 10.1371/journal.ppat.1000450, 2679223, 19478868.
21. Courgnaud V, Pourrut X, Bibollet-Ruche F, Mpoudi-Ngole E, Bourgeois A, Delaporte E, Peeters M. Characterization of a Novel Simian Immunodeficiency Virus from Guereza Colobus Monkeys (Colobus guereza) in Cameroon: a New Lineage in the Nonhuman Primate Lentivirus Family. J Virol 2001, 75:857-866. 10.1128/JVI.75.2.857-866.2001, 113982, 11134299.
22. Hahn BH, Shaw GM, De KM, Cock, Sharp PM. AIDS as a Zoonosis: Scientific and Public Health Implications. Science 2000, 287:607-614. 10.1126/science.287.5453.607, 10649986.
23. Huet T, Cheynier R, Meyerhans A, Roelants G, Wain-Hobson S. Genetic organization of a chimpanzee lentivirus related to HIV-1. Nature 1990, 345:356-359. 10.1038/345356a0, 2188136.
24. Gao F, Bailes E, Robertson DL, Chen Y, Rodenburg CM, Michael SF, Cummins LB, Arthur LO, Peeters M, Shaw GM, Sharp PM, Hahn BH. Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature 1999, 397:436-441. 10.1038/17130, 9989410.
25. Barlow KL, Ajao AO, Clewley JP. Characterization of a Novel Simian Immunodeficiency Virus (SIVmonNG1) Genome Sequence from a Mona Monkey (Cercopithecus mona). J Virol 2003, 77:6879-6888. 10.1128/JVI.77.12.6879-6888.2003, 156208, 12768007.
26. Courgnaud V, Abela B, Pourrut X, Mpoudi-Ngole E, Loul S, Delaporte E, Peeters M. Identification of a New Simian Immunodeficiency Virus Lineage with a vpu Gene Present among Different Cercopithecus Monkeys (C. mona, C. cephus, and C. nictitans) from Cameroon. J Virol 2003, 77:12523-12534. 10.1128/JVI.77.23.12523-12534.2003, 262559, 14610175.
27. Courgnaud V, Salemi M, Pourrut X, Mpoudi-Ngole E, Abela B, Auzel P, Bibollet-Ruche F, Hahn B, Vandamme A-M, Delaporte E, Peeters M. Characterization of a Novel Simian Immunodeficiency Virus with a vpu Gene from Greater Spot-Nosed Monkeys (Cercopithecus nictitans) Provides New Insights into Simian/Human Immunodeficiency Virus Phylogeny. J Virol 2002, 76:8298-8309. 10.1128/JVI.76.16.8298-8309.2002, 155126, 12134035.
28. Dazza M-C, Ekwalanga M, Nende M, Shamamba KB, Bitshi P, Paraskevis D, Saragosti S. Characterization of a Novel vpu-Harboring Simian Immunodeficiency Virus from a Dent's Mona Monkey (Cercopithecus mona denti). J Virol 2005, 79:8560-8571. 10.1128/JVI.79.13.8560-8571.2005, 1143702, 15956597.
29. Malim MH, Emerman M. HIV-1 Accessory Proteins--Ensuring Viral Survival in a Hostile Environment. Cell Host & Microbe 2008, 3:388-398.
30. Sharp PM, Shaw GM, Hahn BH. Simian Immunodeficiency Virus Infection of Chimpanzees. J Virol 2005, 79:3891-3902. 10.1128/JVI.79.7.3891-3902.2005, 1061584, 15767392.
31. Gomez LM, Pacyniak E, Flick M, Hout DR, Gomez ML, Nerrienet E, Ayouba A, Santiago ML, Hahn BH, Stephens EB. Vpu-mediated CD4 down-regulation and degradation is conserved among highly divergent SIVcpz strains. Virology 2005, 335:46-60. 10.1016/j.virol.2005.01.049, 15823605.
32. Pacyniak E, Gomez ML, Gomez LM, Mulcahy ER, Jackson M, Hout DR, Wisdom BJ, Stephens EB. Identification of a Region within the Cytoplasmic Domain of the Subtype B Vpu Protein of Human Immunodeficiency Virus Type 1 (HIV-1) That Is Responsible for Retention in the Golgi Complex and Its Absence in the Vpu Protein from a Subtype C HIV-1. AIDS Research and Human Retroviruses 2005, 21:379-394. 10.1089/aid.2005.21.379, 15929700.
33. Douglas JL, Viswanathan K, McCarroll MN, Gustin JK, Fruh K, Moses AV. Vpu Directs the Degradation of the Human Immunodeficiency Virus Restriction Factor BST-2/Tetherin via a {beta}TrCP-Dependent Mechanism. J Virol 2009, 83:7931-7947. 10.1128/JVI.00242-09, 2715753, 19515779.
34. Takehisa J, Kraus MH, Ayouba A, Bailes E, Van Heuverswyn F, Decker JM, Li Y, Rudicell RS, Learn GH, Neel C, Ngole EM, Shaw GM, Peeters M, Sharp PM, Hahn BH. Origin and Biology of Simian Immunodeficiency Virus in Wild-Living Western Gorillas. J Virol 2009, 83:1635-1648. 10.1128/JVI.02311-08, 2643789, 19073717.
35. Wain LV, Bailes E, Bibollet-Ruche F, Decker JM, Keele BF, Van Heuverswyn F, Li Y, Takehisa J, Ngole EM, Shaw GM, Peeters M, Hahn BH, Sharp PM. Adaptation of HIV-1 to Its Human Host. Mol Biol Evol 2007, 24:1853-1860. 10.1093/molbev/msm110, 17545188.
36. Sauter D, Schindler M, Specht A, Landford WN, Münch J, Kim K-A, Votteler J, Schubert U, Bibollet-Ruche F, Keele BF, Takehisa J, Ogando Y, Ochsenbauer C, Kappes JC, Ayouba A, Peeters M, Learn GH, Shaw G, Sharp PM, Bieniasz P, Hahn BH, Hatziioannou T, Kirchhoff F. Tetherin-Driven Adaptation of Vpu and Nef Function and the Evolution of Pandemic and Nonpandemic HIV-1 Strains. Cell Host Microbe 2009, 6:409-421. 10.1016/j.chom.2009.10.004, 19917496.
37. Miyagi E, Andrew AJ, Kao S, Strebel K. Vpu enhances HIV-1 virus release in the absence of Bst-2 cell surface down-modulation and intracellular depletion. Proceedings of the National Academy of Sciences 2009, 106:2868-2873.
38. Klimkait T, Strebel K, Hoggan MD, Martin MA, Orenstein JM. The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release. J Virol 1990, 64:621-629. 249152, 2404139.
39. Ritter GD, Yamshchikov G, Cohen SJ, Mulligan MJ. Human immunodeficiency virus type 2 glycoprotein enhancement of particle budding: role of the cytoplasmic domain. J Virol 1996, 70:2669-2673. 190121, 8642705.
40. Schindler M, Münch J, Kutsch O, Li H, Santiago ML, Bibollet-Ruche F, Müller-Trutwin MC, Novembre FJ, Peeters M, Courgnaud V, Bailes E, Roques P, Sodora DL, Silvestri G, Sharp PM, Hahn BH, Kirchhoff F. Nef-Mediated Suppression of T Cell Activation Was Lost in a Lentiviral Lineage that Gave Rise to HIV-1. Cell 2006, 125:1055-1067. 10.1016/j.cell.2006.04.033, 16777597.
41. Kirchhoff F. Is the high virulence of HIV-1 an unfortunate coincidence of primate lentiviral evolution?. Nat Rev Micro 2009, 7:467-476.
42. Nguyen K-L, Llano M, Akari H, Miyagi E, Poeschla EM, Strebel K, Bour S. Codon optimization of the HIV-1 vpu and vif genes stabilizes their mRNA and allows for highly efficient Rev-independent expression. Virology 2004, 319:163-175. 10.1016/j.virol.2003.11.021, 15015498.
43. Noble B, Abada P, Nunez-Iglesias J, Cannon PM. Recruitment of the Adaptor Protein 2 Complex by the Human Immunodeficiency Virus Type 2 Envelope Protein Is Necessary for High Levels of Virus Release. J Virol 2006, 80:2924-2932. 10.1128/JVI.80.6.2924-2932.2006, 1395462, 16501101.
44. Müller-Trutwin MC, S C, Souquière S, Roques P, Versmisse P, Ayouba A, Delarue S, Nerrienet E, Lewis J, Martin P, Simon F, Barré-Sinoussi F, Mauclère P. SIVcpz from a naturally infected Cameroonian chimpanzee: biological and genetic comparison with HIV-1 N. J Med Primatology 2000, 29:166-172.
45. Hirsch VM, Olmsted RA, Murphey-Corb M, Purcell RH, Johnson PR. An African primate lentivirus (SIVsm) closely related to HIV-2. Nature 1989, 339:389-392. 10.1038/339389a0, 2786147.
46. Novembre FJ, Hirsch VM, McClure HM, Fultz PN, Johnson PR. SIV from stump-tailed macaques: Molecular characterization of a highly transmissible primate lentivirus. Virology 1992, 186:783-787. 10.1016/0042-6822(92)90047-S, 1733112.
47. Müller MC, Barré-Sinoussi F. SIVagm: genetic and biological features associated with replication. Front Biosci 2003, 8:d1170-1185. 10.2741/1130, 12957815.
48. Hirsch VM, Dapolito GA, Goldstein S, McClure H, Emau P, Fultz PN, Isahakia M, Lenroot R, Myers G, Johnson PR. A distinct African lentivirus from Sykes' monkeys. J Virol 1993, 67:1517-1528. 237522, 8382307.
49. Hirsch VM, Campbell BJ, Bailes E, Goeken R, Brown C, Elkins WR, Axthelm M, Murphey-Corb M, Sharp PM. Characterization of a Novel Simian Immunodeficiency Virus (SIV) from L'Hoest Monkeys (Cercopithecus l'hoesti): Implications for the Origins of SIVmnd and Other Primate Lentiviruses. J Virol 1999, 73:1036-1045. 103923, 9882304.
50. Le Tortorec A, Neil SJD. Antagonism to and Intracellular Sequestration of Human Tetherin by the Human Immunodeficiency Virus Type 2 Envelope Glycoprotein. J Virol 2009, 83:11966-11978. 10.1128/JVI.01515-09, 19740980.